Ouro Fino Saúde Animal Participações S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 09, 2023
Share
Ouro Fino Saúde Animal Participações S.A. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was BRL 231.84 million compared to BRL 235.31 million a year ago. Net loss was BRL 70.4 million compared to net income of BRL 23.55 million a year ago. Basic loss per share from continuing operations was BRL 1.30931 compared to basic earnings per share from continuing operations of BRL 0.43794 a year ago. Diluted loss per share from continuing operations was BRL 1.30931 compared to diluted earnings per share from continuing operations of BRL 0.43794 a year ago.
For the six months, sales was BRL 399.02 million compared to BRL 437.62 million a year ago. Net loss was BRL 73.8 million compared to net income of BRL 39.54 million a year ago. Basic loss per share from continuing operations was BRL 1.3726 compared to basic earnings per share from continuing operations of BRL 0.73542 a year ago. Diluted loss per share from continuing operations was BRL 1.3726 compared to diluted earnings per share from continuing operations of BRL 0.73542 a year ago.
Ouro Fino Saude Animal Participacoes S.A., also known as Ourofino, is a Brazil-based company engaged in the animal health market business sector in Latin America. The Company manufactures veterinary products using scientific technology in the Company's laboratories. The Company's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.
OURO FINO SAÚDE ANIMAL PARTICIPAÇÕES S.A. 
